Welcome to The Health Collective, a groundbreaking collaboration between renowned researchers from top global academic institutions and OnTracka, the MedTech Company specialising in Clinical Trails and Real-World Data Collection.
The Health Collective is dedicated to transforming the understanding and safe application of Medical Cannabis through a combination of structured and unstructured real-world data to advance credible findings on dosing, safety, and outcomes of Cannabis Medicines for indications that include pain, endometriosis, depression, anxiety, PTSD, sleep disorders, and more.
Pioneering Medical Cannabis Research
Researchers are currently working with the largest real-world dataset on Medical Cannabis, with over 1.2M unique data points from more than 6,000 patients, provided by Australian MedTech company OnTracka.
OnTracka is committed to enhancing these findings with further data that has greater controls, increased volume of structured data, and more comprehensive patient outcomes to ensure a robust analysis of medical cannabis effects.
Pain
Sleep
Cancer
PTSD
Depression
Anxiety
Endometriosis
More
Industry Collaboration
Engage 30+ companies to advance Australian Medical Cannabis research
Informing Policy
Provide credible data to government for evidence-based policy making
Patient Outcomes
Improve care with comprehensive data on dosing, efficacy, and safety
Education
Develop materials to increase understanding of medical cannabis treatments
Our Mission and Key Objectives
Our mission is to build the world’s largest and most trusted data repository on the safety, efficacy, risks, and outcomes of cannabis-based medicines, setting a new standard for research and patient care.
Industry Research Supporters
logo here
logo here
logo here
logo here
logo here
Roadmap
Get involved
For Companies
Power research to showcase the quality and safety of your medicine.
For Clinics
Help shape the guidance on the future prescribing of Cannabis and involve your patients in this study.
For Patients
Participate in this once-in-a-generation reintroduction of Cannabis as a legitimate option for patients.
© 2024 The Health Collective. A program under OnTracka.
The Research Team
Hannah Adler, PhD Candidate
Hannah is an early-career researcher in the fields of health communication and health sociology. Her research expertise covers topics such as medicinal cannabis and endometriosis, where she has completed both communications and community-based research projects.
Dr Amelia Mardon
Dr Amelia Mardon is an early career researcher with expertise in endometriosis, pelvic pain, and women’s health more broadly. She is the study coordinator of the EndoCann Trial, which is investigating the efficacy of medicinal cannabis for endometriosis.
Chad Walkaden
Chad's personal battle with health challenges ignited a passion to transform healthcare. As the founder of OnTracka, he is leading the charge to empower patients through decentralized clinical trials and real-world data studies, revolutionizing patient engagement in healthcare.
Mark Gannott
Mark is a pharmacoeconomist with a background in neurogenomics. He studies valuation as well as the economics of women’s health, endometriosis, cannabis, psychedelics, racism and healthcare. He is the CEO of an insights/solutions firm interweaving science, finance, marketing, and fundraising.
Toobah Farooq, PhD Candidate
Ms. Toobah Farooqi combines academic excellence with a commitment to improving health outcomes. Her involvement in clinical trials, including the Gynoclear trial, and studies on medicinal cannabis for dysmenorrhea and menopause symptoms, equips her to effectively manage recruitment and participant retention.
Dr Orit Holtzman
Dr Orit Holtzman MBBS (USYD), PhD (Neuroscience) is one of Australia’s most experienced cannabinoid medicine practitioners and educators. Co-founder and Director of Leura Wellness Clinic, Co-founder and President of the Australian and New Zealand College of Cannabinoid Practitioners (ANZCCP). Adjunct Fellow, NICM, Western Sydney University.
Ryan Castle, PhD Candidate
Ryan Castle serves as Director of Research at Whole Health Oncology, Inc. and manages scientific collaborations at the Chopra Foundation. Castle conducts public health research, focusing on behavioral medicine, inflammation, mindfulness, disease burdens, altered states of consciousness, and systems theory.
Allie Eathorne
Allie is a statistician and data manager, with particular interest in Asthma, Complementary and Alternative Medicine, Emergency Medicine, Medicinal Cannabis, and Women’s Health.
Prof Alex Semprini
Alex is a clinical triallist with a background in biomedical science, clinical medicine and PhD in clinical research. Alex has specific interests in community based research methodology, pragmatic trials and complementary and alternative medicines.
Justin Sinclair, PhD Candidate
Justin is a pharmacognosist that has spent the last 20 years studying medicinal plants, with a specific focus on cannabis. He is currently completing his doctoral studies investigating the safety, tolerability and effectiveness of medicinal cannabis in endometriosis.
Nial, Director of Academic Excellence at Macquarie University, has 24+ years of experience, led curriculum initiatives, managed pharmacy programs at the University of Sydney, and served in the Royal Australian Navy.
Prof Nial Wheate (Founding Academic)
A/Prof Mike Armour (Academic lead)
A/Prof Mike Armour is an academic expert in women’s health and medicinal cannabis. He has published over 110 papers on women’s health and currently runs multiple clinical studies on medicinal cannabis and various aspects of women’s health including endometriosis, period pain, and menopause.